<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="italic;} Int J Infect DisInt. J. Infect. DisInternational Journal of" exact="Infectious" post="Diseases1201-97121878-3511The Author(s). Published by Elsevier Ltd on behalf of"/>
 <result pre="Published by Elsevier Ltd on behalf of International Society for" exact="Infectious" post="Diseases. pmcid: 7441048S1201-9712(20)30671-8 doi: 10.1016/j.ijid.2020.08.041 : Short Communication Current"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="strategies of testing and sampling sites were examined at different" exact="disease" post="stages. •The choice of test depends on technical characteristics,"/>
 <result pre="characteristics, clinical scenarios and requirements. Abstract The outbreak of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), which began in Wuhan,"/>
 <result pre="clinical scenarios and requirements. Abstract The outbreak of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), which began in Wuhan, Hubei"/>
 <result pre="scenarios and requirements. Abstract The outbreak of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), which began in Wuhan, Hubei Province,"/>
 <result pre="spread of SARS-CoV-2. There are currently several diagnostic techniques (e.g." exact="viral" post="culture and nucleic acid amplification test) being used to"/>
 <result pre="of the currently available laboratory diagnostic assays for detecting SARS-CoV-2" exact="infection" post="and summarized the selection strategies of testing and sampling"/>
 <result pre="the selection strategies of testing and sampling sites at different" exact="disease" post="stages to improve the diagnostic accuracy of Coronavirus Disease"/>
 <result pre="different disease stages to improve the diagnostic accuracy of Coronavirus" exact="Disease" post="2019 (COVID-19). Keywords Novel coronavirus SARS-CoV-2 COVID-19 Laboratory testing"/>
 <result pre="SARS-CoV-2 COVID-19 Laboratory testing Laboratory diagnosis An outbreak of coronavirus" exact="disease" post="2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus"/>
 <result pre="An outbreak of coronavirus disease 2019 (COVID-19) caused by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan,"/>
 <result pre="outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China,"/>
 <result pre="of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China, in"/>
 <result pre="into a global pandemic. As of 29 May 2020 a" exact="total" post="of 5,701,337 laboratory-confirmed COVID-19 cases had been reported worldwide,"/>
 <result pre="in the community, early and reliable laboratory confirmation of SARS-CoV-2" exact="infection" post="is of crucial importance. This review summarized advances made"/>
 <result pre="advances made in technologies for rapid diagnosis and confirmation of" exact="respiratory" post="infections caused by SARS-CoV-2, as well as the selection"/>
 <result pre="made in technologies for rapid diagnosis and confirmation of respiratory" exact="infections" post="caused by SARS-CoV-2, as well as the selection strategies"/>
 <result pre="sampling sites in SARS-CoV-2 detection. Since the initial cases of" exact="pneumonia" post="of unknown cause were first reported, viral culture and"/>
 <result pre="initial cases of pneumonia of unknown cause were first reported," exact="viral" post="culture and genetic sequencing of isolates obtained from these"/>
 <result pre="10 days in January 2020. This benefitted understanding of the" exact="disease" post="occurrence and transmission, as well as diagnostic test development"/>
 <result pre="well as diagnostic test development (Zhu et al., 2020). Although" exact="viral" post="culture is relatively time-consuming and labor-intensive, it is much"/>
 <result pre="Table 1 Testing type Specimen type Characteristics Testing time Limitation" exact="Viral" post="culture Respiratory sample Gold standard for virus diagnosis and"/>
 <result pre="Testing type Specimen type Characteristics Testing time Limitation Viral culture" exact="Respiratory" post="sample Gold standard for virus diagnosis and useful in"/>
 <result pre="be widely used in clinical settings NAAT, whole genome sequencing" exact="Respiratory" post="sample and blood Detects all pathogens in a given"/>
 <result pre="pathogens in a given specimen, including SARS-CoV-2, as well as" exact="viral" post="genome mutations 20 h Time-consuming, specialized instruments with high"/>
 <result pre="with high technical thresholds, and high cost NAAT, real-time RT-PCR" exact="Respiratory" post="sample, stool and blood Most widely used for laboratory"/>
 <result pre="and blood Most widely used for laboratory confirmation of SARS-CoV-2" exact="infection" post="1.5–3 h Time-consuming procedure, requires biosafety conditions, expensive equipment,"/>
 <result pre="personnel, and can have false negative results NAAT, isothermal amplification" exact="Respiratory" post="sample, stool and blood Requires only a single temperature"/>
 <result pre="and blood Less time required, simple to operate, useful in" exact="disease" post="surveillance and epidemiologic research 15–45 min Cross-reaction with other"/>
 <result pre="15–45 min Cross-reaction with other subtypes of coronaviruses Point-of-care test" exact="Respiratory" post="sample Provides rapid actionable information with good sensitivity and"/>
 <result pre="reverse transcription polymerase chain reaction (RT-PCR) is routinely used in" exact="acute" post="respiratory infection to detect causative viruses from respiratory specimens."/>
 <result pre="transcription polymerase chain reaction (RT-PCR) is routinely used in acute" exact="respiratory" post="infection to detect causative viruses from respiratory specimens. The"/>
 <result pre="polymerase chain reaction (RT-PCR) is routinely used in acute respiratory" exact="infection" post="to detect causative viruses from respiratory specimens. The World"/>
 <result pre="used in acute respiratory infection to detect causative viruses from" exact="respiratory" post="specimens. The World Health Organization (WHO) recommends that patients"/>
 <result pre="detecting SARS-CoV-2 RNA have been developed worldwide, with different targeted" exact="viral" post="genes or regions (Table S1). To date, 13 and"/>
 <result pre="to the selection of sampling locations, poor sample quality, low" exact="viral" post="load of the specimen, incorrect storage and transportation, as"/>
 <result pre="asymptomatic infections. The entire test could be completed in a" exact="short" post="time, and be independent of specific equipment or places."/>
 <result pre="and 90.63% in blood samples, respectively (Li et al., 2020b)." exact="Combined" post="IgM–IgG tests provided better sensitivity than tests for only"/>
 <result pre="et al., 2020). Besides, serological testing is critically useful in" exact="disease" post="surveillance and epidemiologic research. A community seroprevalence study of"/>
 <result pre="have an immediate impact on patient management and control of" exact="infectious disease" post="epidemics (Kozel and Burnham-Marusich, 2017). At the time of"/>
 <result pre="an immediate impact on patient management and control of infectious" exact="disease" post="epidemics (Kozel and Burnham-Marusich, 2017). At the time of"/>
 <result pre="of SARS-CoV-2 (Table 2). To prevent misdiagnosis caused by insufficient" exact="viral" post="load, bronchoalveolar lavage fluid (BALF) is the most preferred"/>
 <result pre="lavage fluid (BALF) is the most preferred specimen, as the" exact="viral" post="loads of respiratory tract specimens are highest in BALF,"/>
 <result pre="is the most preferred specimen, as the viral loads of" exact="respiratory" post="tract specimens are highest in BALF, followed by sputum,"/>
 <result pre="et al., 2020). Due to the prolonged presence of SARS-CoV-2" exact="viral" post="RNA in fecal samples and potential fecal-oral transmission, fecal"/>
 <result pre="SARS-CoV-2 is highly recommended when there is virus negativity in" exact="respiratory" post="tract specimens (Wu et al., 2020). In addition, sampling"/>
 <result pre="Specimen type Positive ratea Priority of specimen Early stage/initial diagnosis" exact="Advanced" post="stage Recovery/follow-up Remarks Oropharyngeal swab 32–48% ⋆ Recommended Recommended"/>
 <result pre="stage Recovery/follow-up Remarks Oropharyngeal swab 32–48% ⋆ Recommended Recommended Recommended" exact="Viral" post="loads in the upper respiratory tract peak soon within"/>
 <result pre="swab 32–48% ⋆ Recommended Recommended Recommended Viral loads in the" exact="upper" post="respiratory tract peak soon within one week after symptom"/>
 <result pre="32–48% ⋆ Recommended Recommended Recommended Viral loads in the upper" exact="respiratory" post="tract peak soon within one week after symptom onset"/>
 <result pre="Highly recommended Highly recommended Nasopharyngeal swab samples generally show higher" exact="viral" post="loads and positive rates than oropharyngeal swab samples. Bronchoalveolar"/>
 <result pre="BALF could be collected from patients presenting with more severe" exact="disease" post="or undergoing mechanical ventilation. Sputum 72–76% Highly recommended Highly"/>
 <result pre="Highly recommend Fecal testing for SARS-CoV-2 is highly recommended after" exact="viral" post="clearance in the respiratory samples. aAll patients were confirmed"/>
 <result pre="for SARS-CoV-2 is highly recommended after viral clearance in the" exact="respiratory" post="samples. aAll patients were confirmed by SARS-CoV-2 detection (Wang"/>
 <result pre="into full consideration. Moreover, to improve the detection accuracy of" exact="infectious diseases" post="with COVID-19, proper collection of specimens is of great"/>
 <result pre="April 202032306853 GuoL.RenL.YangS.XiaoM.ChangYangF.Profiling early humoral response to diagnose novel coronavirus" exact="disease" post="(COVID-19)Clin Infect Dis2020PubMed PMID: 32198501. Pubmed Central PMCID: PMC7184472."/>
 <result pre="diagnose novel coronavirus disease (COVID-19)Clin Infect Dis2020PubMed PMID: 32198501. Pubmed" exact="Central" post="PMCID: PMC7184472. Epub 22 March 2020 KozelT.R.Burnham-MarusichA.R.Point-of-care testing for"/>
 <result pre="Central PMCID: PMC7184472. Epub 22 March 2020 KozelT.R.Burnham-MarusichA.R.Point-of-care testing for" exact="infectious" post="diseases: past, present, and futureJ Clin Microbiol558201723132320PubMed PMID: 28539345."/>
 <result pre="diseases: past, present, and futureJ Clin Microbiol558201723132320PubMed PMID: 28539345. Pubmed" exact="Central" post="PMCID: PMC5527409. Epub 26 May 201728539345 LiY.YaoL.LiJ.ChenL.SongY.CaiZ.Stability issues of"/>
 <result pre="patients clinically diagnosed with COVID-19J Med Virol2020PubMed PMID: 32219885. Pubmed" exact="Central" post="PMCID: PMC7228231. Epub 29 March 2020 LiZ.YiY.LuoX.XiongN.LiuY.LiS.Development and clinical"/>
 <result pre="application of a rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosisJ Med Virol2020PubMed PMID: 32104917. Pubmed Central PMCID: PMC7228300."/>
 <result pre="test for SARS-CoV-2 infection diagnosisJ Med Virol2020PubMed PMID: 32104917. Pubmed" exact="Central" post="PMCID: PMC7228300. Epub 28 February 2020 SoodN.SimonP.EbnerP.EichnerD.ReynoldsJ.BendavidE.Seroprevalence of SARS-CoV-2-specific"/>
 <result pre="Angeles County, California, on April 10–11, 2020JAMA2020PubMed PMID: 32421144. Pubmed" exact="Central" post="PMCID: PMC7235907. Epub 19 May 2020 WangW.XuY.GaoR.LuR.HanK.WuG.Detection of SARS-CoV-2"/>
 <result pre="SARS-CoV-2 in different types of clinical specimensJAMA2020PubMed PMID: 32159775. Pubmed" exact="Central" post="PMCID: PMC7066521. Epub 12 March 2020 WuY.GuoC.TangL.HongZ.ZhouJ.DongX.Prolonged presence of"/>
 <result pre="PMCID: PMC7066521. Epub 12 March 2020 WuY.GuoC.TangL.HongZ.ZhouJ.DongX.Prolonged presence of SARS-CoV-2" exact="viral" post="RNA in faecal samplesLancet Gastroenterol Hepatol552020434435PubMed PMID: 32199469. Pubmed"/>
 <result pre="viral RNA in faecal samplesLancet Gastroenterol Hepatol552020434435PubMed PMID: 32199469. Pubmed" exact="Central" post="PMCID: PMC7158584. Epub 23 March 202032199469 XiaoA.T.TongY.X.ZhangS.False-negative of RT-PCR"/>
 <result pre="in COVID-19: rather than recurrenceJ Med Virol2020PubMed PMID: 32270882. Pubmed" exact="Central" post="PMCID: PMC7262304. Epub 10 April 2020 XieX.ZhongZ.ZhaoW.ZhengC.WangF.LiuJ.Chest CT for"/>
 <result pre="2019-nCoV pneumonia: relationship to negative RT-PCR testingRadiology2020200343PubMed PMID: 32049601. Pubmed" exact="Central" post="PMCID: PMC7233363. Epub 13 February 2020 YanC.CuiJ.HuangL.DuB.ChenL.XueG.Rapid and visual"/>
 <result pre="Pubmed Central PMCID: PMC7233363. Epub 13 February 2020 YanC.CuiJ.HuangL.DuB.ChenL.XueG.Rapid and" exact="visual" post="detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse"/>
 <result pre="transcription loop-mediated isothermal amplification assayClin Microbiol Infect2662020773779PubMed PMID: 32276116. Pubmed" exact="Central" post="PMCID: PMC7144850. Epub 11 April 202032276116 YangY.YangM.ShenC.WangF.YuanJ.LiJ.Evaluating the accuracy"/>
 <result pre="PMC7144850. Epub 11 April 202032276116 YangY.YangM.ShenC.WangF.YuanJ.LiJ.Evaluating the accuracy of different" exact="respiratory" post="specimens in the laboratory diagnosis and monitoring the viral"/>
 <result pre="different respiratory specimens in the laboratory diagnosis and monitoring the" exact="viral" post="shedding of 2019-nCoV infectionsmedRxiv20202020.02.11.20021493 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A novel coronavirus from patients"/>
 <result pre="shedding of 2019-nCoV infectionsmedRxiv20202020.02.11.20021493 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019New Engl J Med2020PubMed PMID: 31978945 Appendix"/>
</results>
